Incorporating Retasure's retinal assessment tools, we are able to expand the services we provide to physicians, allowing them to increase their quality of care for patients. Finding eye complications earlier means diabetic patients will have a much better chance of preserving their vision.
Wake Forest, NC (PRWEB) April 29, 2009
Diagnostic Imaging Solutions, Inc. has selected Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics.
Established in 2006, Diagnostic Imaging Solutions, Inc. is among Colorado's leading mobile ultrasound imaging companies. With a team of highly qualified and experienced staff offering the latest in technology, Diagnostic Imaging Solutions, Inc., adds diabetic retinal screening to the full range of mobile services they offer to physicians and their offices. Diagnostic Imaging Solutions, Inc. delivers personalized care and health-related services consistent with the highest quality medical and ethical standards to improve the health status of the people they serve.
"Our goal is to provide physicians with as many quality mobile on-site services as possible," said Jason Russo, President of Diagnostic Imaging Solutions. "Incorporating Retasure's retinal assessment tools, we are able to expand the services we provide to physicians, allowing them to increase their quality of care for patients. Finding eye complications earlier means diabetic patients will have a much better chance of preserving their vision."
The Retasure™ solution developed by Digital Healthcare provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure network to an accredited reading center. Scott Sanner, Senior Vice President of North American Operations for Digital Healthcare agrees. "Retasure ™ in the primary care setting improves the chances of prevention of unnecessary sight loss. The National Eye Institute states that diabetic retinopathy is the leading cause of blindness among working age adults in America," he says, "but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication."
Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; and it obtains exceptionally high-quality digital images of the retina. This FDA-approved technology is used by a broad range of doctors and facilities throughout the United States and the United Kingdom, including leading hospitals and research centers, primary care groups, private ophthalmology and optometry groups, family practice residency centers, and internal, multi-specialty and endocrinology groups.
For additional information, please visit http://www.retasure.com
CONTACT: Scott Sanner (866) 539-4213